• This record comes from PubMed

Regulation of Src family kinases involved in T cell receptor signaling by protein-tyrosine phosphatase CD148

. 2011 Jun 24 ; 286 (25) : 22101-12. [epub] 20110504

Language English Country United States Media print-electronic

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Grant support
R01 AI066120 NIAID NIH HHS - United States
AI066120 NIAID NIH HHS - United States

Links

PubMed 21543337
PubMed Central PMC3121354
DOI 10.1074/jbc.m110.196733
PII: S0021-9258(19)48917-5
Knihovny.cz E-resources

CD148 is a receptor-like protein-tyrosine phosphatase known to inhibit transduction of mitogenic signals in non-hematopoietic cells. Similarly, in the hematopoietic lineage, CD148 inhibited signal transduction downstream of T cell receptor. However, it also augmented immunoreceptor signaling in B cells and macrophages via dephosphorylating C-terminal tyrosine of Src family kinases (SFK). Accordingly, endogenous CD148 compensated for the loss of the main SFK activator CD45 in murine B cells and macrophages but not in T cells. Hypothetical explanations for the difference between T cells and other leukocyte lineages include the inability of CD148 to dephosphorylate a specific set of SFKs involved in T cell activation or the lack of CD148 expression during critical stages of T cell development. Here we describe striking differences in CD148 expression between human and murine thymocyte subsets, the only unifying feature being the absence of CD148 during the positive selection when the major developmental block occurs under CD45 deficiency. Moreover, we demonstrate that similar to CD45, CD148 has both activating and inhibitory effects on the SFKs involved in TCR signaling. However, in the absence of CD45, activating effects prevail, resulting in functional complementation of CD45 deficiency in human T cell lines. Importantly, this is independent of the tyrosines in the CD148 C-terminal tail, contradicting the recently proposed phosphotyrosine displacement model as a mechanism of SFK activation by CD148. Collectively, our data suggest that differential effects of CD148 in T cells and other leukocyte subsets cannot be explained by the CD148 inability to activate T cell SFKs but rather by its dual inhibitory/activatory function and specific expression pattern.

See more in PubMed

Hermiston M. L., Zikherman J., Zhu J. W. (2009) Immunol. Rev. 228, 288–311 PubMed PMC

Honda H., Inazawa J., Nishida J., Yazaki Y., Hirai H. (1994) Blood 84, 4186–4194 PubMed

Kuramochi S., Matsuda S., Matsuda Y., Saitoh T., Ohsugi M., Yamamoto T. (1996) FEBS Lett. 378, 7–14 PubMed

Zhang L., Martelli M. L., Battaglia C., Trapasso F., Tramontano D., Viglietto G., Porcellini A., Santoro M., Fusco A. (1997) Exp. Cell Res. 235, 62–70 PubMed

Autschbach F., Palou E., Mechtersheimer G., Rohr C., Pirotto F., Gassler N., Otto H. F., Schraven B., Gaya A. (1999) Tissue Antigens 54, 485–498 PubMed

Schraven B., Hegen M., Autschbach F., Gaya A., Schwartz C., Meuer S. (1997) in Leukocyte Typing VI (Kishimoto T. ed) pp. 576–580, Garland Publishing, Inc., New York

de la Fuente-García M. A., Nicolás J. M., Freed J. H., Palou E., Thomas A. P., Vilella R., Vives J., Gayá A. (1998) Blood 91, 2800–2809 PubMed

Tangye S. G., Phillips J. H., Lanier L. L., de Vries J. E., Aversa G. (1998) J. Immunol. 161, 3249–3255 PubMed

Gayà A., Pirotto F., Palou E., Autschbach F., Del Pozo V., Solé J., Serra-Pages C. (1999) Leuk. Lymphoma 35, 237–243 PubMed

Lin J., Zhu J. W., Baker J. E., Weiss A. (2004) J. Immunol. 173, 2324–2330 PubMed

Ruivenkamp C. A., van Wezel T., Zanon C., Stassen A. P., Vlcek C., Csikós T., Klous A. M., Tripodis N., Perrakis A., Boerrigter L., Groot P. C., Lindeman J., Mooi W. J., Meijjer G. A., Scholten G., Dauwerse H., Paces V., van Zandwijk N., van Ommen G. J., Demant P. (2002) Nat. Genet. 31, 295–300 PubMed

Trapasso F., Iuliano R., Boccia A., Stella A., Visconti R., Bruni P., Baldassarre G., Santoro M., Viglietto G., Fusco A. (2000) Mol. Cell. Biol. 20, 9236–9246 PubMed PMC

Massa A., Barbieri F., Aiello C., Arena S., Pattarozzi A., Pirani P., Corsaro A., Iuliano R., Fusco A., Zona G., Spaziante R., Florio T., Schettini G. (2004) J. Biol. Chem. 279, 29004–29012 PubMed

Ruivenkamp C., Hermsen M., Postma C., Klous A., Baak J., Meijer G., Demant P. (2003) Oncogene 22, 3472–3474 PubMed

Trapasso F., Yendamuri S., Dumon K. R., Iuliano R., Cesari R., Feig B., Seto R., Infante L., Ishii H., Vecchione A., During M. J., Croce C. M., Fusco A. (2004) Carcinogenesis 25, 2107–2114 PubMed

Balavenkatraman K. K., Jandt E., Friedrich K., Kautenburger T., Pool-Zobel B. L., Ostman A., Böhmer F. D. (2006) Oncogene 25, 6319–6324 PubMed

Keane M. M., Lowrey G. A., Ettenberg S. A., Dayton M. A., Lipkowitz S. (1996) Cancer Res. 56, 4236–4243 PubMed

Kovalenko M., Denner K., Sandström J., Persson C., Gross S., Jandt E., Vilella R., Böhmer F., Ostman A. (2000) J. Biol. Chem. 275, 16219–16226 PubMed

Chabot C., Spring K., Gratton J. P., Elchebly M., Royal I. (2009) Mol. Cell. Biol. 29, 241–253 PubMed PMC

Grazia, Lampugnani M., Zanetti A., Corada M., Takahashi T., Balconi G., Breviario F., Orsenigo F., Cattelino A., Kemler R., Daniel T. O., Dejana E. (2003) J. Cell Biol. 161, 793–804 PubMed PMC

Palka H. L., Park M., Tonks N. K. (2003) J. Biol. Chem. 278, 5728–5735 PubMed

Tsuboi N., Utsunomiya T., Roberts R. L., Ito H., Takahashi K., Noda M., Takahashi T. (2008) Biochem. J. 413, 193–200 PubMed

Pera I. L., Iuliano R., Florio T., Susini C., Trapasso F., Santoro M., Chiariotti L., Schettini G., Viglietto G., Fusco A. (2005) Oncogene 24, 3187–3195 PubMed

Zhu J. W., Brdicka T., Katsumoto T. R., Lin J., Weiss A. (2008) Immunity 28, 183–196 PubMed PMC

Senis Y. A., Tomlinson M. G., Ellison S., Mazharian A., Lim J., Zhao Y., Kornerup K. N., Auger J. M., Thomas S. G., Dhanjal T., Kalia N., Zhu J. W., Weiss A., Watson S. P. (2009) Blood 113, 4942–4954 PubMed PMC

Matozaki T., Murata Y., Mori M., Kotani T., Okazawa H., Ohnishi H. (2010) Cell. Signal. 22, 1811–1817 PubMed

Zheng X. M., Resnick R. J., Shalloway D. (2000) EMBO J. 19, 964–978 PubMed PMC

Palou E., de la Fuente-García M. A., Nicolás J. M., Vilardell C., Vives J., Gayá A. (1997) Immunol. Lett. 57, 101–103 PubMed

Baker J. E., Majeti R., Tangye S. G., Weiss A. (2001) Mol. Cell. Biol. 21, 2393–2403 PubMed PMC

Tangye S. G., Wu J., Aversa G., de Vries J. E., Lanier L. L., Phillips J. H. (1998) J. Immunol. 161, 3803–3807 PubMed

Lin J., Weiss A. (2003) J. Cell Biol. 162, 673–682 PubMed PMC

Weiss A., Stobo J. D. (1984) J. Exp. Med. 160, 1284–1299 PubMed PMC

Peyron J. F., Verma S., de Waal Malefyt R., Sancho J., Terhorst C., Spits H. (1991) Int. Immunol. 3, 1357–1366 PubMed

Shiroo M., Goff L., Biffen M., Shivnan E., Alexander D. (1992) EMBO J. 11, 4887–4897 PubMed PMC

Koretzky G. A., Picus J., Schultz T., Weiss A. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 2037–2041 PubMed PMC

Res P., Blom B., Hori T., Weijer K., Spits H. (1997) J. Exp. Med. 185, 141–151 PubMed PMC

Patel D. D., Hale L. P., Wichard L. P., Radcliff G., Mackay C. R., Haynes B. F. (1995) in Leukocyte Typing V (Schlossman S. F. ed) pp. 1725–1727, Oxford University Press, New York

Stauder R., Terpe H. J., Stark H., Thaler J., Mackay C., Gunthert U. (1995) in Leukocyte Typing V (Schlossman S. F. ed) pp. 1719–1723, Oxford University Press, New York

Chu D. H., Spits H., Peyron J. F., Rowley R. B., Bolen J. B., Weiss A. (1996) EMBO J. 15, 6251–6261 PubMed PMC

Murata Y., Mori M., Kotani T., Supriatna Y., Okazawa H., Kusakari S., Saito Y., Ohnishi H., Matozaki T. (2010) Genes Cells 15, 513–524 PubMed

Cale C. M., Klein N. J., Novelli V., Veys P., Jones A. M., Morgan G. (1997) Arch. Dis. Child 76, 163–164 PubMed PMC

Kung C., Pingel J. T., Heikinheimo M., Klemola T., Varkila K., Yoo L. I., Vuopala K., Poyhonen M., Uhari M., Rogers M., Speck S. H., Chatila T., Thomas M. L. (2000) Nat. Med. 6, 343–345 PubMed

Tchilian E. Z., Wallace D. L., Wells R. S., Flower D. R., Morgan G., Beverley P. C. L. (2001) J. Immunol. 166, 1308–1313 PubMed

Hermiston M. L., Xu Z., Weiss A. (2003) Annu. Rev. Immunol. 21, 107–137 PubMed

Schabath R., Ratei R., Ludwig W. D. (2003) Best Pract. Res. Clin. Haematol. 16, 613–628 PubMed

Marks D. I., Paietta E. M., Moorman A. V., Richards S. M., Buck G., DeWald G., Ferrando A., Fielding A. K., Goldstone A. H., Ketterling R. P., Litzow M. R., Luger S. M., McMillan A. K., Mansour M. R., Rowe J. M., Tallman M. S., Lazarus H. M. (2009) Blood 114, 5136–5145 PubMed PMC

Wuchter C., Ruppert V., Schrappe M., Dörken B., Ludwig W. D., Karawajew L. (2002) Blood 99, 4109–4115 PubMed

Ellison S., Mori J., Barr A. J., Senis Y. A. (2010) J. Thromb. Haemost. 8, 1575–1583 PubMed

Nika K., Soldani C., Salek M., Paster W., Gray A., Etzensperger R., Fugger L., Polzella P., Cerundolo V., Dushek O., Höfer T., Viola A., Acuto O. (2010) Immunity 32, 766–777 PubMed PMC

Zikherman J., Jenne C., Watson S., Doan K., Raschke W., Goodnow C. C., Weiss A. (2010) Immunity 32, 342–354 PubMed PMC

McNeill L., Salmond R. J., Cooper J. C., Carret C. K., Cassady-Cain R. L., Roche-Molina M., Tandon P., Holmes N., Alexander D. R. (2007) Immunity 27, 425–437 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...